Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotics for Microorganisms in Overactive Bladder
NCT00883818Phase 4Completed
- Sponsor
- Samsung Medical Center
- Start
- Jan 2007
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of azithromycin and doxycycline in overactive bladder (OAB), sponsored by Samsung Medical Center. Primary endpoint: Percentage of positive cultures for M. hominis, U. urealyticum and C. trachomatis in women with OAB symptoms. Started Jan 2007; status: completed.
02
Drugs
azithromycindoxycycline
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT00883818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00883818.